Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix

International Journal of Gynecological Cancer

Volumn 10, Issue 5, 2000, Pages 358-365

  Vermorken, J B ^a   Mangioni, C ^a   Pecorelli, S ^a   Van Der Burg, M E L ^a   Van Oosterom, A T ^a   Ten Bokkel Huinink, W W ^a   Rotmensz, N ^a   Dalesio, O ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cervical cancer; Chemotherapy; Metastatic disease

Indexed keywords

BLEOMYCIN; CISPLATIN; MITOMYCIN C; VINCRISTINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISSEMINATED CANCER; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0033710830     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010005358.x     Document Type: Article

References (23)

1. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review
2. Chemotherapy as a palliative treatment in carcinoma of the uterine cervix
3. Chemotherapy for stage IVB or recurrent cervical cancer
4. Randomized of cisplatin versus cisplatin plus mitolactol (Dibromodulcitol) versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study
5. Cancer of the uterine cervix
6. Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspective
7. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
8. Chemotherapy of cervical carcinoma
9. The response of human lymphoma cells in vitro to bleomycin and 1, 3 Bis(2-chloroethyl)-1-nitrosurea
10. Reporting results of cancer treatment
11. Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C and diamminedichloroplatinum (II) (BOMP)
12. Combination chemotherapy for patients with advanced carcinoma of the cervix: Trial of mitomycin C, vincristine, bleomycin and cisplatin
13. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinoma: A high incidence of pulmonary toxicity
14. Chemotherapy for advanced and/or recurrent cervical cancer
15. Bleomycin, vincristine, mitomycin C, and cisplatin in the management of gynecological squamous cell carcinomas
16. Mitomycin C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamaous cell carcinoma of the cervix
17. Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin C and low dose consecutive cisplatin
18. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix
19. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix
20. Cisplatin-based combination chemotherapy (BEMP) versus single agent cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix (SCCUC): Mature data of EORTC protocol 55863
21. Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin
22. Palliative chemotherapy for patients with cervical cancer. What is standard
23. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study